Oxford Global is proud to present the 3rd Annual Biosimilars & Biobetters Congress, where delegates will have a unique opportunity to hear industry key opinion leaders discussing the current landscape of biosimilars. 

The conference focuses on the key areas of the current biosimilars industry spread over two interactive streams. On day one our experts will explore market access strategies, opportunities and commercial challenges. Hot topic to be discussed include the latest regulatory updates on EU and US biosimilars, case studies on novel commercialisation strategies and the opportunities emerging markets offer. 

On day two presentations will focus on developing biosimilars and biobetters. Esteemed biosimilar leaders will address the future challenges and obstacles of biosimilar development, clinical and non-clinical advances in biosimilars and industry mAB development case studies. The Biosimilars Congress is co-located with our 8th Annual Proteins & Antibodies and 2nd Annual Peptides Congress. 

For further information click here